Cargando…
Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of MECP2 Deficiency and Is a Potential Therapy for Rett Syndrome
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818197/ https://www.ncbi.nlm.nih.gov/pubmed/34025262 http://dx.doi.org/10.1177/1535759720960469 |
| _version_ | 1783638783808241664 |
|---|---|
| author | Lamar, Kay-Marie Joan Carvill, Gemma L. |
| author_facet | Lamar, Kay-Marie Joan Carvill, Gemma L. |
| author_sort | Lamar, Kay-Marie Joan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7818197 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78181972021-01-28 Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of MECP2 Deficiency and Is a Potential Therapy for Rett Syndrome Lamar, Kay-Marie Joan Carvill, Gemma L. Epilepsy Curr Current Literature in Basic Science SAGE Publications 2020-09-30 /pmc/articles/PMC7818197/ /pubmed/34025262 http://dx.doi.org/10.1177/1535759720960469 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Current Literature in Basic Science Lamar, Kay-Marie Joan Carvill, Gemma L. Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of MECP2 Deficiency and Is a Potential Therapy for Rett Syndrome |
| title | Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a
Model of MECP2 Deficiency and Is a Potential Therapy for Rett
Syndrome |
| title_full | Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a
Model of MECP2 Deficiency and Is a Potential Therapy for Rett
Syndrome |
| title_fullStr | Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a
Model of MECP2 Deficiency and Is a Potential Therapy for Rett
Syndrome |
| title_full_unstemmed | Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a
Model of MECP2 Deficiency and Is a Potential Therapy for Rett
Syndrome |
| title_short | Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a
Model of MECP2 Deficiency and Is a Potential Therapy for Rett
Syndrome |
| title_sort | free as a brd4: bromodomain inhibition ameliorates disease phenotypes in a
model of mecp2 deficiency and is a potential therapy for rett
syndrome |
| topic | Current Literature in Basic Science |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818197/ https://www.ncbi.nlm.nih.gov/pubmed/34025262 http://dx.doi.org/10.1177/1535759720960469 |
| work_keys_str_mv | AT lamarkaymariejoan freeasabrd4bromodomaininhibitionamelioratesdiseasephenotypesinamodelofmecp2deficiencyandisapotentialtherapyforrettsyndrome AT carvillgemmal freeasabrd4bromodomaininhibitionamelioratesdiseasephenotypesinamodelofmecp2deficiencyandisapotentialtherapyforrettsyndrome |